Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: RAMM Pharma Corp.

Market Cap 1.79M 1.28M 1.1M 1.02M 953K 121M 1.81M 12.01M 4.69M 59.29M 4.81M 4.71M 205M P/E Ratio 2024
-0.07x
P/E Ratio 2025 -0.2x
Enterprise Value 1.07M 764K 658K 606K 568K 72.16M 1.08M 7.16M 2.8M 35.34M 2.87M 2.8M 122M EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
6 months-40.00%
Current year-75.00%
1 month 0.01
Extreme 0.01
0.02
Current year 0.01
Extreme 0.01
0.05
1 year 0.01
Extreme 0.01
0.25
3 years 0
Extreme 0
0.25
5 years 0
Extreme 0
1
10 years 0
Extreme 0
1.19
Manager TitleAgeSince
Chief Executive Officer - 01/10/2019
Director of Finance/CFO - 09/12/2022
Director TitleAgeSince
Director/Board Member - 01/10/2019
Director/Board Member 82 01/10/2019
Director/Board Member 66 01/10/2019
Date Insider Type Main position Quantity % Market Cap.
02/06/25Sell

Chief Executive Officer

4,667,000 3.9091%
21/03/25Buy

Chief Executive Officer

200,000 0.1675%
21/03/25Buy

Chief Executive Officer

100,000 0.0838%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+50.00%-70.00% 1.28M
-0.32%-1.72%+37.83%+148.79% 1,007B
-2.16%+1.51%+50.01%+43.93% 567B
-2.70%-0.66%+15.97%+63.07% 392B
-0.28%+1.05%+20.91%+18.37% 328B
-0.46%+1.13%+24.23%+31.91% 277B
+0.83%-2.38%+23.02%+12.89% 275B
-0.45%+5.21%-43.07%-48.62% 196B
-1.31%+1.39%+18.74%+53.45% 189B
-1.03%-2.97%+13.02%+57.34% 154B
Average +0.11%+0.30%+21.06%+31.11% 338.6B
Weighted average by Cap. +0.23%-0.03%+26.50%+67.13%

Financials

2024 2025
Net sales 4.34M 3.11M 2.68M 2.46M 2.31M 294M 4.39M 29.13M 11.38M 144M 11.66M 11.41M 497M 3.36M 2.4M 2.07M 1.91M 1.79M 227M 3.39M 22.55M 8.81M 111M 9.02M 8.83M 385M
Net income -16.5M -11.81M -10.18M -9.36M -8.79M -1.12B -16.67M -111M -43.24M -546M -44.3M -43.36M -1.89B -8.91M -6.37M -5.49M -5.06M -4.74M -602M -9M -59.77M -23.35M -295M -23.92M -23.41M -1.02B
Net Debt -626K -448K -386K -355K -333K -42.31M -632K -4.2M -1.64M -20.72M -1.68M -1.64M -71.69M -723K -518K -446K -411K -385K -48.91M -731K -4.85M -1.9M -23.95M -1.94M -1.9M -82.89M
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-
  1. Stock Market
  2. Stocks
  3. RAMM Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!